Ooi SL, Rae J, Pak SC. Implementation of evidence-based practice: A naturopath perspective. Complement Ther Clin Pract. 2016;22:24–8.
Article
PubMed
Google Scholar
Leach MJ. Clinical decision making in complementary and alternative medicine. Sydney: Churchill Livingstone; 2010.
Google Scholar
Field MJ, Lohr KN. Clinical practice guidelines: directions for a new program. Washington: National Academy Press; 1990.
Google Scholar
Truman BI, Smith-Akin CK, Hinman AR, Gebbie KM, Brownson R, Novick LF, Lawrence RS, Pappaioanou M, Fielding J, Evans Jr CA, et al. Developing the Guide to Community Preventive Services--overview and rationale. The Task Force on Community Preventive Services. Am J Prev Med. 2000;18(1 Suppl):18–26.
Article
CAS
PubMed
Google Scholar
Woolf SH, DiGuiseppi CG, Atkins D, Kamerow DB. Developing evidence-based clinical practice guidelines: lessons learned by the US Preventive Services Task Force. Annu Rev Public Health. 1996;17:511–38.
Article
CAS
PubMed
Google Scholar
Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ. 1999;318(7183):593–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
WHO. Guidelines for WHO guidelines. Geneva: World Health Organisation; 2003. p. 46.
Google Scholar
Eccles M, Mason J. How to develop cost-conscious guidelines. Health Technol Assess. 2001;5(16):1–69.
Article
CAS
PubMed
Google Scholar
Woolf S, Schunemann HJ, Eccles MP, Grimshaw JM, Shekelle P. Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations. Implement Sci. 2012;7:61.
Article
PubMed
PubMed Central
Google Scholar
Edejer TT. Improving the use of research evidence in guideline development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications. Health Res Policy Syst. 2006;4:23.
Article
PubMed
PubMed Central
Google Scholar
NHMRC. Review of the Australian Government Rebate on Natural Therapies for Private Health Insurance. Canberra: Commonwealth of Australia; 2015.
Brouwers M, Kho ME, Browman GP, Cluzeau F, feder G, Fervers B, Hanna S, Makarski J on behalf of the AGREE Next Steps Consortium. AGREE II Instrument: Advancing guideline development, reporting and evaluation in healthcare. The AGREE Research Trust, May 2009, UPDATE: September 2013. [http://www.agreetrust.org/]. Accessed 1 Sept 2014.
Semlitsch T, Blank WA, Kopp IB, Siering U, Siebenhofer A. Evaluating Guidelines: A Review of Key Quality Criteria. Dtsch Arztebl Int. 2015;112(27–28):471–8.
PubMed
PubMed Central
Google Scholar
Ernst E. Assessments of complementary and alternative medicine: the clinical guidelines from NICE. Int J Clin Pract. 2010;64(10):1350–8.
Article
CAS
PubMed
Google Scholar
Ernst E, Terry R. NICE guidelines on complementary/alternative medicine: more consistency and rigour are needed. Br J Gen Pract. 2009;59(566):695.
Article
PubMed
PubMed Central
Google Scholar
Lorenc A, Leach J, Robinson N. Clinical guidelines in the UK: Do they mention Complementary and alternative medicine (CAM) – Are CAM professional bodies aware? Eur J Intern Med. 2014;6(2):164–75.
Article
Google Scholar
Robinson N, Lui J, Lee MS. Clinical guidelines: The way for best practice. Eur J Intern Med. 2014;6(2):133–4.
Article
Google Scholar
Andrews JC, Schunemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, Rind D, Montori VM, Brito JP, Norris S, et al. GRADE guidelines: 15. Going from evidence to recommendation: determinants of a recommendation's direction and strength. J Clin Epidemiol. 2013;66(7):726–35.
Article
PubMed
Google Scholar
Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, Nasser M, Meerpohl J, Post PN, Kunz R, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66(7):719–25.
Article
PubMed
Google Scholar
Oxman AD, Lavis JN, Fretheim A, Lewin S. SUPPORT Tools for evidence-informed health Policymaking (STP) 17: Dealing with insufficient research evidence. Health Res Policy Syst. 2009;7 Suppl 1:S17.
Article
PubMed
Google Scholar
Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med. 2009;150(3):199–205.
Article
PubMed
Google Scholar
Walach H, Falkenberg T, Fonnebo V, Lewith G, Jonas WB. Circular instead of hierarchical: methodological principles for the evaluation of complex interventions. BMC Med Res Methodol. 2006;6:29.
Article
PubMed
PubMed Central
Google Scholar
Walach H, Loef M. Using a matrix-analytical approach to synthesising evidence solved incompatibility problem in the Hierarchy of Evidence. J Clin Epidemiol. 2015.
Greenhalgh T, Howick J, Maskrey N. Evidence based medicine: a movement in crisis? BMJ. 2014;13:348.
Google Scholar
Noblit G, Hare R. Meta-ethnography: synthesizing qualitative studies. Newbury Park: Sage; 1988.
Book
Google Scholar
Dixon-Woods M, Cavers D, Agarwal S, Annandale E, Arthur A, Harvey J, Hsu R, Katbamna S, Olsen R, Smith L, et al. Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Med Res Methodol. 2006;6:35.
Article
PubMed
PubMed Central
Google Scholar
Schunemann HJ, Wiercioch W, Etxeandia I, Falavigna M, Santesso N, Mustafa R, Ventresca M, Brignardello-Petersen R, Laisaar KT, Kowalski S, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ. 2014;186(3):E123–142.
Article
PubMed
PubMed Central
Google Scholar
Booth A, Harris J, Croot E, Springett J, Campbell F, Wilkins E. Towards a methodology for cluster searching to provide conceptual and contextual "richness" for systematic reviews of complex interventions: case study (CLUSTER). BMC Med Res Methodol. 2013;13:118.
Article
PubMed
PubMed Central
Google Scholar
Bodeker GBG. Traditional, Complementary and Alternative Medicine: Policy and Public health Perspectives. UK: Oxford University; 2007.
Google Scholar
Paterson C, Baarts C, Launso L, Verhoef MJ. Evaluating complex health interventions: a critical analysis of the 'outcomes' concept. BMC Complement Altern Med. 2009;9:18.
Article
PubMed
PubMed Central
Google Scholar
Coulter ID, Willis EM. The rise and rise of complementary and alternative medicine: a sociological perspective. Med J Aust. 2004;180(11):587–9.
PubMed
Google Scholar
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94.
Article
PubMed
Google Scholar
Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6.
Article
PubMed
Google Scholar
Brunetti M, Shemilt I, Pregno S, Vale L, Oxman AD, Lord J, Sisk J, Ruiz F, Hill S, Guyatt GH, et al. GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. J Clin Epidemiol. 2013;66(2):140–50.
Article
PubMed
Google Scholar
GRADE Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. In: Schünemann H, Brożek J, Guyatt G, Oxman A, editors. 2013.
Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schunemann HJ. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395–400.
Article
PubMed
Google Scholar
Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Falck-Ytter Y, Jaeschke R, Vist G, et al. GRADE guidelines: 8. Rating the quality of evidence--indirectness. J Clin Epidemiol. 2011;64(12):1303–10.
Article
PubMed
Google Scholar
Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Glasziou P, Jaeschke R, Akl EA, et al. GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol. 2011;64(12):1294–302.
Article
PubMed
Google Scholar
Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, Alonso-Coello P, Djulbegovic B, Atkins D, Falck-Ytter Y, et al. GRADE guidelines: 5. Rating the quality of evidence--publication bias. J Clin Epidemiol. 2011;64(12):1277–82.
Article
PubMed
Google Scholar
Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R, Brozek J, Norris S, Meerpohl J, Djulbegovic B, et al. GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol. 2013;66(2):158–72.
Article
PubMed
Google Scholar
Guyatt GH, Oxman AD, Schunemann HJ. GRADE guidelines-an introduction to the 10th-13th articles in the series. J Clin Epidemiol. 2013;66(2):121–3.
Article
PubMed
Google Scholar
Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, Atkins D, Kunz R, Brozek J, Montori V, et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol. 2011;64(12):1311–6.
Article
PubMed
Google Scholar
Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, Montori V, Akl EA, Djulbegovic B, Falck-Ytter Y, et al. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407–15.
Article
PubMed
Google Scholar
Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, Johnston BC, Karanicolas P, Akl EA, Vist G, et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol. 2013;66(2):173–83.
Article
PubMed
Google Scholar
GRADEpro GDT [www.gradepro.org]. Accessed 4 April 2016
Lavis JN, Oxman AD, Lewin S, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP). Health Res Policy Syst. 2009;7 Suppl 1:I1.
Article
PubMed
PubMed Central
Google Scholar
Fretheim A, Munabi-Babigumira S, Oxman AD, Lavis JN, Lewin S. SUPPORT Tools for evidence-informed health Policymaking (STP) 6: Using research evidence to address how an option will be implemented. Health Res Policy Syst. 2009;7 Suppl 1:S6.
Article
PubMed
Google Scholar
Fretheim A, Oxman AD, Lavis JN, Lewin S. SUPPORT Tools for evidence-informed health Policymaking (STP) 18: Planning monitoring and evaluation of policies. Health Res Policy Syst/BioMed Centra. 2009;7 Suppl 1:S18.
Article
Google Scholar
Lavis JN, Boyko JA, Oxman AD, Lewin S, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 14: Organising and using policy dialogues to support evidence-informed policymaking. Health Res Policy Syst. 2009;7 Suppl 1:S14.
Article
PubMed
Google Scholar
Lavis JN, Oxman AD, Grimshaw J, Johansen M, Boyko JA, Lewin S, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 7: Finding systematic reviews. Health Res Policy Syst. 2009;7 Suppl 1:S7.
Article
PubMed
Google Scholar
Lavis JN, Oxman AD, Lewin S, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 3: Setting priorities for supporting evidence-informed policymaking. Health Res Policy Syst. 2009;7 Suppl 1:S3.
Article
PubMed
Google Scholar
Lavis JN, Oxman AD, Souza NM, Lewin S, Gruen RL, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 9: Assessing the applicability of the findings of a systematic review. Health Res Policy Syst. 2009;7 Suppl 1:S9.
Article
PubMed
Google Scholar
Lavis JN, Permanand G, Oxman AD, Lewin S, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 13: Preparing and using policy briefs to support evidence-informed policymaking. Health Res Policy Syst. 2009;7 Suppl 1:S13.
Article
PubMed
Google Scholar
Lavis JN, Wilson MG, Oxman AD, Grimshaw J, Lewin S, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 5: Using research evidence to frame options to address a problem. Health Res Policy Syst. 2009;7 Suppl 1:S5.
Article
PubMed
Google Scholar
Lavis JN, Wilson MG, Oxman AD, Lewin S, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 4: Using research evidence to clarify a problem. Health Res Policy Syst. 2009;7 Suppl 1:S4.
Article
PubMed
Google Scholar
Lewin S, Oxman AD, Lavis JN, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 8: Deciding how much confidence to place in a systematic review. Health Res Policy Syst. 2009;7 Suppl 1:S8.
Article
PubMed
Google Scholar
Lewin S, Oxman AD, Lavis JN, Fretheim A, Garcia Marti S, Munabi-Babigumira S. SUPPORT Tools for evidence-informed health Policymaking (STP) 11: Finding and using evidence about local conditions. Health Res Policy Syst. 2009;7 Suppl 1:S11.
Article
PubMed
Google Scholar
Oxman AD, Fretheim A, Lavis JN, Lewin S. SUPPORT Tools for evidence-informed health Policymaking (STP) 12: Finding and using research evidence about resource use and costs. Health Res Policy Syst. 2009;7 Suppl 1:S12.
Article
PubMed
Google Scholar
Oxman AD, Lavis JN, Fretheim A, Lewin S. SUPPORT Tools for evidence-informed health Policymaking (STP) 16: Using research evidence in balancing the pros and cons of policies. Health Res Policy Syst. 2009;7 Suppl 1:S16.
Article
PubMed
Google Scholar
Oxman AD, Lavis JN, Lewin S, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 10: Taking equity into consideration when assessing the findings of a systematic revie. Health Res Policy Syst. 2009;7 Suppl 1:S10.
Article
PubMed
Google Scholar
Oxman AD, Lavis JN, Lewin S, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 1: What is evidence-informed policymaking? Health Res Policy Syst. 2009;7 Suppl 1:S1.
Article
PubMed
Google Scholar
Oxman AD, Lewin S, Lavis JN, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 15: Engaging the public in evidence-informed policymaking. Health Res Policy Syst. 2009;7 Suppl 1:S15.
Article
PubMed
Google Scholar
Oxman AD, Vandvik PO, Lavis JN, Fretheim A, Lewin S. SUPPORT Tools for evidence-informed health Policymaking (STP) 2: Improving how your organisation supports the use of research evidence to inform policymaking. Health Res Policy Syst. 2009;7 Suppl 1:S2.
Article
PubMed
Google Scholar
NHMRC. A guide to the development, evaluation and implementation of clinical practice guidelines. National Health & Medical Research Council. Canberra: Commonwealth of Australia; 1999.
Google Scholar
Hillier S, Grimmer-Somers K, Merlin T, Middleton P, Salisbury J, Tooher R, Weston A. FORM: an Australian method for formulating and grading recommendations in evidence-based clinical guidelines. BMC Med Res Methodol. 2011;11:23.
Article
PubMed
PubMed Central
Google Scholar
Merlin T, Weston A, Tooher R, Middleton P, Salisbury J, Coleman K, Norris S, Grimmer-Somers K, Hillier S. NHMRC additional levels of evidence and grades for recommendations for developers of guidelines. Australia: National Health and Medical Research Council; 2009.
Google Scholar
German Association of the Scientific Medical Societies (AWMF) - Standing Guidelines Com-mission. AWMF Guidance Manual and Rules for Guideline Development, 1st Edition 2012. English version. Available at: http://www.awmf.org/leitlinien/awmf-regelwerk.html. (Accessed 9 Sept 2014).
SIGN. SIGN 50 - A guideline developer's handbook. Edinburgh: Scottish Intercollegiate Guidelines Network (SIGN); 2014.
Google Scholar
USPSTF: U.S. Preventive Services Task Force Procedure Manual. AHRQ Publication No. 08-05118-EF edn. 2008
Grade Definitions After July 2012. [http://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions]. Accessed 10 April 2014
Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3 Suppl):21–35.
Article
CAS
PubMed
Google Scholar
NICE. Developing NICE guidelines: the manual. Process and methods guide. London: National Institute for Health and Care Excellence; 2014.
Google Scholar
NICE. The guidelines manual. Process and methods guide. London: National Institute for Health and Care Excellence; 2012.
Google Scholar
Thornton J, Alderson P, Tan T, Turner C, Latchem S, Shaw E, Ruiz F, Reken S, Mugglestone MA, Hill J, et al. Introducing GRADE across the NICE clinical guideline program. J Clin Epidemiol. 2013;66(2):124–31.
Article
PubMed
Google Scholar
Boon H, Macpherson H, Fleishman S, Grimsgaard S, Koithan M, Norheim AJ, Walach H. Evaluating Complex Healthcare Systems: A Critique of Four Approaches. Evid Based Complement Alternat Med. 2007;4(3):279–85.
Article
PubMed
Google Scholar
Deng G, Weber W, Sood A, Kemper KJ. Research on integrative healthcare: context and priorities. Explore (NY). 2010;6(3):143–58.
Article
Google Scholar
Hunter J, Corcoran K, Leeder S, Phelps K. Integrative medicine outcomes: What should we measure? Complement Ther Clin Pract. 2013;19(1):20–6.
Article
PubMed
Google Scholar
MacPherson H. Acupuncture for depression: state of the evidence. Acupunct Med. 2014;32(4):304–5.
Article
PubMed
Google Scholar
Smith Caroline A, Hay Phillipa PJ, MacPherson H. Acupuncture for depression. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 2010.
Costanzo S, di Niro V, Di Castelnuovo A, Gianfagna F, Donati MB, de Gaetano G, Iacoviello L. Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis. J Thorac Cardiovasc Surg. 2013;146(4):906–11.
Article
CAS
PubMed
Google Scholar
Xin W, Wei W, Lin Z, Zhang X, Yang H, Zhang T, Li B, Mi S. Fish oil and atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials. PLoS One. 2013;8(9):e72913.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu H. The Effect of Fish Oil on Hemostasis and Coagulations During Cardiac Surgery. SCA Bulletin: Drug & Innovation Update; 2013. 12(2). http://www.scahq.org/sca3/newsletters/2013apr/diu.html.
Makarski J, Brouwers MC. The AGREE Enterprise: a decade of advancing clinical practice guidelines. Implement Sci. 2014;9:103.
Article
PubMed
PubMed Central
Google Scholar
Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;4:CD002978.
Google Scholar
Rossouw JE, Manson JE, Kaunitz AM, Anderson GL. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy. Obstet Gynecol. 2013;121(1):172–6.
Article
PubMed
PubMed Central
Google Scholar
Beer AM, Osmers R, Schnitker J, Bai W, Mueck AO, Meden H. Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms - comments on major statements of the Cochrane Collaboration report 2012 "black cohosh (Cimicifuga spp.) for menopausal symptoms (review). Gynecol Endocrinol. 2013;29(12):1022–5.
Article
PubMed
Google Scholar
Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev. 2012;9:CD007244.
Google Scholar
Peng W, Adams J, Sibbritt DW, Frawley JE. Critical review of complementary and alternative medicine use in menopause: focus on prevalence, motivation, decision-making, and communication. Menopause. 2014;21(5):536–48.
Article
PubMed
Google Scholar
Posadzki P, Lee MS, Moon TW, Choi TY, Park TY, Ernst E. Prevalence of complementary and alternative medicine (CAM) use by menopausal women: a systematic review of surveys. Maturitas. 2013;75(1):34–43.
Article
CAS
PubMed
Google Scholar
Gentry-Maharaj A, Karpinskyj C, Glazer C, Burnell M, Ryan A, Fraser L, Lanceley A, Jacobs I, Hunter MS, Menon U. Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study. Menopause. 2015;22(4):384–90.
Article
PubMed
PubMed Central
Google Scholar
Gores KM, Hamieh TS, Schmidt GA. Survival following investigational treatment of amanita mushroom poisoning: thistle or shamrock? Chest. 2014;146(4):e126–129.
Article
PubMed
Google Scholar
Mengs U, Pohl RT, Mitchell T. Legalon(R) SIL: the antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning. Curr Pharm Biotechnol. 2012;13(10):1964–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wilson JX. Mechanism of action of vitamin C in sepsis: ascorbate modulates redox signaling in endothelium. Biofactors. 2009;35(1):5–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fowler 3rd AA, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, Farthing CA, Larus TL, Martin E, Brophy DF, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12:32.
Article
PubMed
PubMed Central
Google Scholar
Jacobs C, Hutton B, Ng T, Shorr R, Clemons M. Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review. Oncologist. 2015;20(2):210–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kongtharvonskul J, Anothaisintawee T, McEvoy M, Attia J, Woratanarat P, Thakkinstian A. Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis. Eur J Med Res. 2015;20:24.
Article
PubMed
PubMed Central
Google Scholar
Bruyere O, Cooper C, Pelletier JP, Branco J, Luisa Brandi M, Guillemin F, Hochberg MC, Kanis JA, Kvien TK, Martel-Pelletier J, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253–63.
Article
PubMed
Google Scholar
Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev. 2008;4:CD000448.
Google Scholar
Raja M, Azzoni A. Hypericum-induced mood disorder: switch from depression to mixed episodes in two patients. Int J Psychiatry Clin Pract. 2006;10(2):146–8.
Article
PubMed
Google Scholar
Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ. 2005;330(7488):385.
Article
CAS
PubMed
PubMed Central
Google Scholar